Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. (Q44445302)
Jump to navigation
Jump to search
scientific article published on 5 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. |
scientific article published on 5 July 2013 |
Statements
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients (English)
O Barreau